FDA Approves Eli Lilly’s GLP-1 Pill
did:plc:ao3t7cr3n5vz5lhwlje3oied
April 1, 2026
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Discussion in the ATmosphere